Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry

Brief Summary
Researchers are creating a real time COVID-19 registry of current ICU/hospital care patterns to allow evaluations of safety and observational effectiveness of COVID-19 practices and to determine the variations in practice across hospitals.
Brief Title
Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry
Detailed Description
Investigators aim is to create a real time COVID-19 registry of current ICU/hospital care patterns to allow evaluations of safety and observational effectiveness of COVID-19 practices and to determine the variations in practice across hospitals.

Such a set of standards would increase the quality of single and multi-center studies, national registries as well as aggregation syntheses such as meta-analyses. It will also be of utmost importance in tiring times of public health emergencies and will help understand practice variability and outcomes during COVID-19 pandemic.
Completion Date
Completion Date Type
Actual
Conditions
Coronavirus
Eligibility Criteria
Inclusion Criteria:

* COVID-19 PCR positive (within 7 days)
* COVID-19 PCR pending
* COVID-19 high clinical suspicion

Exclusion Criteria:

* Patient without Prior Research Authorization (applicable to Mayo Clinic sites)
* Non COVID-19 related admissions
* Repeated Admission to ICUs/Hospital
Inclusion Criteria
Inclusion Criteria:

* COVID-19 PCR positive (within 7 days)
* COVID-19 PCR pending
* COVID-19 high clinical suspicion

Gender
All
Gender Based
false
Keywords
COVID19
Healthy Volunteers
No
Last Update Submit Date
NCT Id
NCT04323787
Org Class
Other
Org Full Name
Mayo Clinic
Org Study Id
20-002610
Overall Status
Completed
Primary Completion Date
Primary Completion Date Type
Actual
Official Title
Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry and Validation of C2D2 (Critical Care Data Dictionary)
Primary Outcomes
Outcome Description
Primary outcome will be to measure ICU and hospital mortality up to 7 days of COVID-19 patients
Outcome Measure
ICU and hospital mortality of COVID-19 patients
Outcome Time Frame
7 days
Secondary Outcomes
Outcome Description
Secondary outcome will be to measure 30 days mortality from Hospital discharge
Outcome Time Frame
30 days
Outcome Measure
30 days mortality
Start Date
Start Date Type
Actual
Status Verified Date
First Submit Date
First Submit QC Date
Study Population
COVID-19 Hospitalized patients
Std Ages
Child
Adult
Older Adult
Maximum Age Number (converted to Years and rounded down)
999
Minimum Age Number (converted to Years and rounded down)
0
Investigators
Investigator Type
Principal Investigator
Investigator Name
Jen-Ting Chen
Investigator Email
jeche@montefiore.org
Investigator Phone
646-229-2304